Evidence map›Paper›PMID 38765810›Full record

ReviewFrontiers in nutrition2024

Current insights into transcriptional role(s) for the nutraceutical

Praful Saha, Saiprasad Ajgaonkar, Dishant Maniar, Simran Sahare, Dilip Mehta, Sujit Nair

Abstract readReview
In one paragraph

Review in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Nutraceutical Applications ofFoods (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Review
  7. Whole genome circRNA profiling ofDrug metabolism and personalized therapy · 2026
    Article
  8. Safety and Tolerability ofFood science & nutrition · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. An open-label, single dose, safety and pharmacokinetic study ofDrug metabolism and personalized therapy · 2025
    Article
  13. Article
  14. Article
  15. Drug target insights
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Praful SahaPhytoVeda Pvt. Ltd., Mumbai, India.
Saiprasad AjgaonkarPhytoVeda Pvt. Ltd., Mumbai, India.
Dishant ManiarPhytoVeda Pvt. Ltd., Mumbai, India.
Simran SaharePhytoVeda Pvt. Ltd., Mumbai, India.
Dilip MehtaPhytoVeda Pvt. Ltd., Mumbai, India.
Sujit NairPhytoVeda Pvt. Ltd., Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health-beneficial effects of nutraceuticals in various diseases have received enhanced attention in recent years. Aging is a continuous process wherein physiological activity of an individual declines over time and is characterized by various indefinite hallmarks which contribute toward aging-related comorbidities in an individual which include many neurodegenerative diseases, cardiac problems, diabetes, bone-degeneration, and cancer. Cellular senescence is a homeostatic biological process that has an important function in driving aging. Currently, a growing body of evidence substantiates the connection between epigenetic modifications and the aging process, along with aging-related diseases. These modifications are now being recognized as promising targets for emerging therapeutic interventions. Considering that almost all the biological processes are modulated by RNAs, numerous RNA-binding proteins have been found to be linked to aging and age-related complexities. Currently, studies have shed light on the ability of the nutraceutical

Indexed as

agingAshwagandhainflammationnoncoding RNAnutraceuticalsRNAtranscriptionWithania somnifera

Identifiers

PMID38765810
PMCPMC11099240

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.